Research Institute of Dallas | Dallas, TX
Status and phase
Conditions
Treatments
About
The purpose of this is study is to evaluate the long-term safety of DCCR (diazoxide choline) extended-release tablets) in patients with Prader-Willi syndrome.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Provide voluntary, written informed consent (parent(s) / legal guardian(s) of patient); provide voluntary, written assent (subjects, as appropriate)
Participant must:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
83 participants in 1 patient group
Loading...
Central trial contact
C614 Project Manager
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal